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MaBACKGROUND Recent studies have demonstrated improved diagnostic accuracy for detecting coronary artery disease
(CAD) when myocardial blood ﬂow (MBF) is quantiﬁed in absolute terms, but there are no uniformly accepted cutoff
values for hemodynamically signiﬁcant CAD.
OBJECTIVES The goal of this study was to determine cutoff values for absolute MBF and to evaluate the diagnostic
accuracy of quantitative [15O]H2O positron emission tomography (PET).
METHODS A total of 330 patients underwent both quantitative [15O]H2O PET imaging and invasive coronary angiog-
raphy in conjunction with fractional ﬂow reserve measurements. A stenosis >90% and/or fractional ﬂow reserve #0.80
was considered obstructive; a stenosis <30% and/or fractional ﬂow reserve >0.80 was nonobstructive.
RESULTS Hemodynamically signiﬁcant CAD was diagnosed in 116 (41%) of 281 patients who fulﬁlled study criteria
for CAD. Resting perfusion was 1.00  0.25 and 0.92  0.23 ml/min/g in regions supplied by nonstenotic and sig-
niﬁcantly stenosed vessels, respectively (p < 0.001). During stress, perfusion increased to 3.26  1.04 ml/min/g and
1.73  0.67 ml/min/g, respectively (p < 0.001). The optimal cutoff values were 2.3 and 2.5 for hyperemic MBF and
myocardial ﬂow reserve, respectively. For MBF, these cutoff values showed a sensitivity, speciﬁcity, and accuracy for
detecting signiﬁcant CAD of 89%, 84%, and 86%, respectively, at a per-patient level and 87%, 85%, and 85% at a
per-vessel level. The corresponding myocardial ﬂow reserve values were 86%, 72%, and 78% (per patient) and 80%,
82%, and 81% (per vessel). Age and sex signiﬁcantly affected diagnostic accuracy of quantitative PET.
CONCLUSIONS Quantitative MBF measurements with the use of [15O]H2O PET provided high diagnostic performance,
but both sex and age should be taken into account. (J Am Coll Cardiol 2014;64:1464–75) © 2014 by the American
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1465AB BR E V I A T I O N S
AND ACRONYM S
CAD = coronary artery disease
CI = conﬁdence interval
CT = computed tomography
FFR = fractional ﬂow reserve
ICA = invasive
coronary angiography
MBF = myocardial blood ﬂowI ncreasingly, cardiac positron emission tomogra-phy (PET) is being used to noninvasively assessmyocardial blood ﬂow (MBF). Traditionally, nu-
clear myocardial perfusion imaging (MPI) is based
on the interpretation of static tracer uptake images.
However, in contrast to single-photon emission
computed tomography MPI, PET can quantify MBF
in absolute terms (1–4). Current commercially avail-
able PET technology has paved the way for routine
quantiﬁcation of MBF.330 patients
enrolled
N = 990 vessels
Stenosis < 30%
N = 417
FFR performed
N = 354
Stenosis > 90%
N = 92
Intermediate stenosis not
interrogated by FFR
N = 127
FFR > 0.80
N = 272
FFR ≤ 0.80
N = 82
Stenosis considered
non-hemodynamically
significant
N = 689
Stenosis considered
hemodynamically
significant
N = 174
FIGURE 1 Study Flow Chart
Study ﬂow chart showing the enrollment of patients and the number of coronary arteries
interrogated by using fractional ﬂow reserve (FFR).
SEE PAGE 1476
MFR = myocardial ﬂow reserve
MPI = myocardial
perfusion imaging
NPV = negative
predictive value
PET = positron
emission tomography
PPV = positive predictive value
ROC = receiver-operator
characteristicSeveral PET tracers, such as rubidium-82 (82Rb),
13N-ammonia (13NH3), and [15O]H2O, have been well
validated and routinely used in clinical practice (5–7).
Recent studies have demonstrated the incremental
diagnostic value of quantitative MBF measurements
above visual grading of tracer uptake images (8,9). One
of the fundamental issues when interpreting quanti-
tative hyperemic MBF results is to deﬁne optimal
cutoff values for distinguishing between normal and
pathological MBF in hemodynamically compromised
epicardial disease. Although previous studies have
reported discriminatory values of hyperemic MBF and
myocardial ﬂow reserve (MFR) (10–17), these studies
were hampered by the lack of a gold standard identi-
fying ﬂow-limiting coronary stenosis and limitations
inherent in single-center studies.
The worldwide interest in quantitative cardiac PET
necessitates use of uniform thresholds to facilitate
patient management, exchange of patient data, and
large multicenter studies that will enforce tighter
guidelines. Although studies have evaluated diag-
nostic performance of qualitative cardiac PET imaging
(9,12,15,17), few data exist on the diagnostic accuracy
of quantitative cardiac PET imaging. Therefore, the
goal of the present study was to determine optimal
diagnostic cutoff values of myocardial perfusion as
assessed with quantitative [15O]H2O PET in a clinical
cohort of patients with suspected coronary artery
disease (CAD). Patients in a large collaborative PET
study underwent both PET MPI and invasive coronary
angiography (ICA) in conjunction with fractional ﬂow
reserve (FFR) assessment. The diagnostic accuracy of
absolute hyperemic MBF and MFR to detect hemody-
namically signiﬁcant CAD as indicated by FFR was
assessed, as was the impact of sex, age, and CAD risk
proﬁle on absolute MBF.
METHODS
STUDY POPULATION. Three institutions participated
in this collaborative PET study: VU University Medi-
cal Center (n ¼ 163), Turku University Hospital(n ¼ 161), and Uppsala University Hospital
(n ¼ 6). The study ﬂow chart is depicted in
Figure 1. With symptoms suggestive of CAD,
patients had been referred for ICA and then
prospectively enrolled to undergo [15O]H2O
PET before ICA. A total of 330 patients were
included. No cardiac events were docu-
mented between PET studies and ICA.
Exclusion criteria were atrial ﬁbrillation, sec-
ond- or third-degree atrioventricular block,
symptomatic asthma, pregnancy, or a docu-
mented history of CAD, (deﬁned as a previous
percutaneous coronary intervention, coro-
nary artery bypass graft surgery, ormyocardial
infarction). In all patients, electrocardiog-
raphy showed no signs of a previous myocar-
dial infarction, and echocardiography, when
performed, showed normal left ventricular
function without wall motion abnormalities.
CAD pre-test likelihood was determined ac-
cording to the Diamond and Forrester criteria (18) by
using cutoffs of <13.4% and >87.2%, for low and high
pre-test likelihoods, respectively, and intermediate
pre-test likelihood for values between these 2 cutoffs.
Each center had institutional review board approval
for the study.
POSITRON EMISSION TOMOGRAPHY. Each patient
underwent a [15O]H2O PET/computed tomography
(CT) study by using a hybrid PET/CT scanner with
TABLE 1 Characteristics of Study Population (N ¼ 330)
Age, yrs 61  9
Male 192 (58)
Length, m 1.72  0.10
Weight, kg 80  15
BMI, kg/m2 27  4
Coronary risk proﬁle
Diabetes mellitus type 2 45 (14)
Hypertension 153 (46)
Hypercholesterolemia 164 (50)
Smoking history 110 (33)
Family history of CAD 100 (30)
Medication
Acetylsalicylic acid 269 (82)
Beta-blockers 208 (63)
Statins 230 (70)
ACE inhibitors 65 (20)
ARBs 51 (16)
CCBs 65 (20)
Type of chest pain
Typical angina 115 (35)
Atypical angina 153 (46)
Aspeciﬁc chest pain 53 (16)
No chest discomfort/high-risk proﬁle 9 (3)
Pre-test likelihood of CAD
Low 20 (6)
Intermediate 270 (82)
High 40 (12)
Values are mean  SD or n (%).
ACE ¼ angiotensin-converting enzyme; ARBs ¼ angiotensin II receptor blockers;
BMI ¼ body mass index; CAD ¼ coronary artery disease; CCB ¼ calcium channel
blocker.
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1466site-speciﬁc protocols. Patients at the VU University
Medical Center were scanned by using a Gemini TF
64 PET/CT scanner (Philips Healthcare, Best, the
Netherlands). The PET scanning protocol has been
described in detail previously (19). Patients at the
Turku University Hospital were scanned on a Dis-
covery VCT PET/CT scanner (GE Medical Systems,
Waukesha, Wisconsin); this protocol was also previ-
ously described (15). Images were reconstructed by
using GE’s standard iterative reconstruction algo-
rithm. The Uppsala University Hospital patients were
scanned on a Discovery ST PET/CT scanner (GE
Medical Systems) in 3-dimensional mode. A 6-min
dynamic PET perfusion scan during resting condi-
tions was started simultaneously with the adminis-
tration of 400 MBq of [15O]H2O. After a 15-min delay
following the ﬁrst injection, an identical PET
sequence was performed during hyperemia. To cor-
rect for photon attenuation and scatter, a single low-
dose (10 mA) respiration-averaged CT scan during
normal breathing was acquired just before the resting
PET scan. Images were reconstructed by using the
ordered subset expectation maximization algorithm
(2 iterations, 28 subsets) into 22 frames (1  10, 8  5,
4  10, 2  15, 3  20, 2  30, and 2  60 s).
All institutions used adenosine to induce hyper-
emia, initiated 2 min before the stress scan for
maximal vasodilation.
QUANTIFICATION OF MBF. Quantitative MBF images
were generated by using 2 previously published soft-
ware packages developed in-house: Cardiac VUer
(used by VU University Medical Center and Uppsala
University Hospital) and Carimas (Turku University
Hospital) (11,20). Both packages extract the arterial
input function directly from the dynamic PET data and
use a single tissue compartmentmodel with correction
for perfusable tissue fraction to generate parametric
MBF images (11,20,21). MBF was expressed in millili-
ters per minute per gram of perfusable tissue. To
account for changes in baseline MBF caused by cardiac
workload, baseline MBF values were corrected for
rate-pressure product, an index of myocardial oxygen
consumption, using the follow equation: corrected
MBF ¼ (MBF/rate-pressure product)  104 (22).
Corrected MFR (MFRcorr) was deﬁned as the ratio of
hyperemic MBF divided by corrected baseline MBF.
ICA AND FFR. ICA imaging was performed according
to standard clinical protocols. The coronary tree was
divided into a 16-segment coronary artery model
modiﬁed from the American Heart Association (23). All
major coronary arteries and side branches >2.0 mm
were interrogated with FFR. An FFR #0.80 was
considered a hemodynamically signiﬁcant stenosis,
and an FFR >0.80 was nonsigniﬁcant. If FFR wasmissing, vessels with a<30% stenosis were considered
functionally not relevant, whereas >90% coronary
stenoses were graded as hemodynamically signiﬁcant.
The operators refrained from FFR measurement in
tight lesions >90% to avoid potentially inﬂicting a
coronary dissection with the pressure wire. All vessels
containing an intermediate stenosis (30% to 90%) not
interrogated with FFR were excluded from analysis.
FFR was measured by using a 0.014-inch sensor-
tipped guidewire, introduced through a 5- or 6-F
guiding catheter. Furthermore, adenosine was
infused using either intravenous (Turku University
Hospital) or intracoronary (Uppsala University Hospi-
tal and VU University Medical Center) administration
with a dosage of 140 mg/kg/min and 150 mg, respec-
tively, in right and left coronary arteries to induce
maximal coronary hyperemia. FFR was calculated as
the ratio of mean distal intracoronary pressure,
measured by pressure wire and mean arterial pressure
measured with the coronary catheter (24).
INTERPRETATION OF PET IMAGING RESULTS. Data
were analyzed on a per-patient and per-vessel basis.
The 3 main vascular territories (right coronary artery,
FIGURE 2 Male, 58-Year-Old Patient With Typical Anginal Chest Pain
Positron emission tomography (PET) showed a perfusion defect with an abnormal hyperemic perfusion of 1.26 ml/min/g and a myocardial ﬂow
reserve (MFR) of 1.61 in the area supplied by the left anterior descending (LAD) artery. Invasive coronary angiography showed angiographic
signiﬁcant >70% luminal narrowing of the LAD artery (1-vessel disease) with an FFR of 0.43. CX ¼ circumﬂex artery; RCA ¼ right coronary
artery; other abbreviation as in Figure 1.
TABLE 2 Systemic Hemodynamics at Baseline and Hyperemia
Total Study
Population
(N ¼ 330)
Nonobstructive
CAD
(n ¼ 165)
Obstructive
CAD
(n ¼ 116)
p Value
(Between-
Group CAD)
Heart rate, beats/min
Baseline 60  9 61  9 59  9 0.16
Hyperemia 81  14 83  14 78  12 0.01
p value <0.001 <0.001 <0.001
Systolic blood pressure, mm Hg
Baseline 129  24 125  22 130  26 0.10
Hyperemia 126  23 122  19 128  27 0.06
p value <0.001 0.14 0.03
Diastolic blood pressure, mm Hg
Baseline 67  12 66  11 67  12 0.53
Hyperemia 65  11 63  10 65  13 0.24
p value <0.001 <0.01 0.02
Mean arterial pressure, mm Hg
Baseline 87  14 85  13 87  15 0.21
Hyperemia 85  14 82  12 85  16 0.15
p value <0.001 0.06 0.04
Rate-pressure product
Baseline 7,805  2,102 7,658  2,068 7,720  2,022 0.81
Hyperemia 10,284  2,756 10,218  2,580 9,948  2,742 0.43
p value <0.001 <0.001 <0.001
Values are mean  SD.
CAD ¼ coronary artery disease.
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1467left anterior descending artery, and circumﬂex artery)
were analyzed separately. Anatomical information
obtained from ICA was used to assess coronary domi-
nance and to allocate a coronary lesion to its subtended
vascular territory on parametric MBF images based on
the 17-myocardial segment model for all cardiac im-
aging of the American Heart Association (25). In addi-
tion, segmental analysis was performed, whereby a
perfusion defect of at least 2 adjacent myocardial seg-
ments was assigned to the right coronary artery or
circumﬂex artery vascular territory; a perfusion defect
of at least 4 adjacent segments was assigned to the left
anterior descending vascular territory. Subsequently,
this regional perfusion value was used for further an-
alyses instead of the mean of MBF or MFR of the pre-
deﬁned vascular territory to avoid impact of
overlapping adjacent vascular regions.
STATISTICAL ANALYSIS. Continuous variables are
presented as mean  SD, whereas categorical vari-
ables are expressed as actual numbers. Continuous
variables between FFR groups were compared by
using the 2-sided Student t test. A receiver-operator
characteristic (ROC) curve analysis and the Youden
index were used to deﬁne PET perfusion cutoff values
with the highest discriminative power. Comparison
of ROC curves was performed by the method of
deLong to calculate the SE of the area under the curve
and the difference between ROC curves (26). Based
on evidence from the literature (10,27), predictorsassociated with hyperemic MBF and MFR such as age,
sex, and traditional cardiac risk factors were selected
for univariate and multivariable linear regression
analyses to examine their effect on myocardial
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FIGURE 3 Quantitative Myocardial Perfusion in Relation to
Functional Severity of CAD
(A) Baseline myocardial blood ﬂow (MBF), hyperemic MBF, and
(B) MFR in relation to functional coronary artery disease (CAD)
severity as indicated by FFR. MFRcorr ¼ myocardial ﬂow reserve
of which the baseline perfusion is corrected for the rate-pressure
product; other abbreviations as in Figures 1 and 2.
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1468perfusion. A linear mixed-effects model with per-
patient random effects was used to account for the
clustering of multiple vessel measurements. Diag-
nostic performance of quantitative PET for detecting
ﬂow-limiting CAD and angiographic obstructive
epicardial disease was determined with sensitivity,
speciﬁcity, negative predictive value (NPV), positive
predictive value (PPV), and accuracy on a per-patient
and per-vessel basis. Chi-square or McNemar tests
were used, as appropriate, to compare diagnostic ac-
curacy of quantitative PET with ICA in conjunction
with FFR. A p value <0.05 was considered statisti-
cally signiﬁcant. All statistical analyses were per-
formed by using IBM SPSS Statistics version 20 (IBM
SPSS Statistics, IBM Corporation, Armonk, New York)
and MedCalc software 12.7.4.0 (MedCalc Software,
Mariakerke, Belgium).
RESULTS
A total of 330 patients (Table 1) underwent both [15O]
H2O PET and ICA in conjunction with FFR and were
enrolled in the study (Figure 1). Obstructive CAD
was diagnosed in 116 (41%) patients, with non-
hemodynamically signiﬁcant CAD observed in 165
(59%) patients who fulﬁlled study criteria for CAD.
FFR values were obtained in 160 (48%) patients, of
whom 30 (19%) received intravenous adenosine dur-
ing FFR measurements, and 130 (81%) received
intracoronary adenosine. FFR measurements were
lacking in 49 (15%) patients with at least 1 interme-
diate coronary stenosis.
On a per-vessel analysis, 174 (17%) vessels con-
tained a ﬂow-limiting stenosis, while nonobstructive
CAD was seen in 689 (70%) vessels (Figure 1). A
total of 127 (13%) vessels were excluded from analysis
because of a lack of FFR measurements to assess
the hemodynamic relevance of an intermediate
stenosis. Figure 2 illustrates a case in which angio-
graphic signiﬁcant CAD was proven to be hemody-
namically signiﬁcant according to both [15O]H2O PET
and FFR measurements. Table 2 summarizes hemo-
dynamic characteristics of all patients. Overall, dur-
ing adenosine-induced hyperemia, heart rate and
rate-pressure product increased signiﬁcantly com-
pared with baseline, whereas a decrease in both dia-
stolic and systolic blood pressures was noted. When
grouped according to FFR, there were no signiﬁcant
differences in hemodynamic parameters, except for
heart rate during hyperemia, which was slightly lower
in patients with functionally relevant CAD.
RELATIONSHIP BETWEEN FUNCTIONAL CAD SEVERITY
AND MBF. On a per-patient level, global MBF was
0.99  0.26 ml/min/g during resting conditions,increasing to 2.91  1.09 ml/min/g during adenosine-
induced hyperemia (p < 0.001), yielding an MFR of
3.05  1.09. On a per-vessel basis, baseline ﬂow
increased from 0.98  0.25 ml/min/g to 2.91  1.14
ml/min/g during hyperemia (p < 0.001), yielding an
MFR of 3.06  1.19. Baseline and hyperemic MBF were
signiﬁcantly lower in areas subtended by vessels with
hemodynamically signiﬁcant stenoses compared with
those without obstructive CAD: 0.92  0.23 ml/min/g
versus 1.00  0.25 ml/min/g and 1.73  0.67 ml/min/g
versus 3.26  1.04 ml/min/g (all p < 0.001) for base-
line and hyperemic MBF, respectively (Figure 3). MFR
and MFRcorr decreased signiﬁcantly (p < 0.001), from
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FIGURE 4 Diagnostic Performance of Quantitative PET Perfusion Parameters
Receiver-operator characteristic (ROC) curve analysis with corresponding area under the
curves (AUCs) and 95% conﬁdence intervals displaying the diagnostic performance of
hyperemic MBF, MFR, MFRcorr, and baseline MBF for the detection of hemodynamically
signiﬁcant CAD as indicated by FFR on a (A) per-patient and (B) per-vessel level.
Abbreviations as in Figures 1 to 3.
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14693.37  1.11 and 2.55  0.93 to 1.99  0.89 and 1.49 
0.63, respectively, in myocardial territories sub-
tended by arteries with obstructive CAD.
DIAGNOSTIC PERFORMANCE OF QUANTITATIVE
[15O]H2O PET FOR DETECTING FLOW-LIMITING
DISEASE. Detecting hemodynamically signiﬁcant
CAD on a per-vessel basis produced area under the
curve values for baseline MBF, hyperemic MBF, MFR,
and MFRcorr of 0.60 (95% conﬁdence interval [CI]:
0.55 to 0.64), 0.90 (95% CI: 0.88 to 0.93), 0.86 (95%
CI: 0.82 to 0.89) and 0.85 (95% CI: 0.82 to 0.89),
respectively (Figure 4). ROC curve analysis revealed
a signiﬁcantly greater diagnostic performance of hy-
peremic MBF than baseline MBF, MFR, and MFRcorr
(all p < 0.001).
Diagnostic performance of the aforementioned
perfusion parameters yielded similar results on a per-
patient basis (Figure 4). Hyperemic MBF produced a
signiﬁcantly higher test performance than baseline
MBF, MFR, and MFRcorr (all p < 0.001). No difference
was seen in overall test performance between MFR
and MFRcor on both a per-vessel (p ¼ 0.88) and per-
patient (p ¼ 0.95) level. The relationship between
hyperemic MBF and estimated probability of CAD is
shown in the Central Illustration. The optimal cutoff
values for predicting hemodynamically signiﬁcant
CAD was 2.3 ml/min/g for hyperemic MBF and 2.5
ml/min/g for MFR. With these cutoff values, the
diagnostic accuracy of hyperemic MBF was compa-
rable on both a per-patient (86%) and per-vessel
(85%) level (Figure 5), whereas the MFR demon-
strated an accuracy of 78% and 81% on a per-patient
and per-vessel basis (Figure 5, Table 3). Hyperemic
MBF outperforms MFR as a perfusion parameter with
regard to speciﬁcity (p < 0.01), and accuracy (p <
0.01).
When applying different FFR values of 0.65, 0.70,
and 0.75 to indicate hemodynamic obstructive CAD,
the optimal cutoff value for hyperemic MBF remained
at 2.3 ml/min/g for all applied FFR thresholds
(Figure 6). The diagnostic accuracy of hyperemic MBF
in relation to different FFR cutoff values for deﬁning
hemodynamic obstructive CAD is shown in Table 4.
Table 5 lists the diagnostic accuracy of quantitative
[15O]H2O PET MPI for detecting angiographic obstruc-
tive CAD using $50% or $70% stenosis on ICA as
thresholds. There was no difference in diagnostic
performance of hyperemic MBF for detecting
obstructive CAD, as indicated by FFR #0.80 between
intracoronary and intravenous use of adenosine for
measuring FFR.
In terms of FFR and myocardial perfusion, discor-
dancy between hyperemic MBF, MFR, MFRcorr, andFFR was observed in 16%, 20%, and 21% of vessels,
respectively (Figure 7). Regression analysis was
performed to identify factors that affect myocardial
perfusion (Table 6). According to univariate analysis,
age (p < 0.01), female sex (p < 0.001), diabetes mel-
litus type 2 (p ¼ 0.01), hypertension (p ¼ 0.02), and
FFR #0.80 (p < 0.001) all signiﬁcantly affected hy-
peremic MBF. Multivariable analysis revealed that
age, sex, hypertension, family history of CAD, and
FFR were independently related to hyperemic MBF.
EFFECTS OF AGE AND SEX ON DIAGNOSTIC
PERFORMANCE OF QUANTITATIVE [15O]H2O PET.
The inﬂuence of sex and age on diagnostic accuracy
CENTRAL ILLUSTRATION Deﬁnition of Optimal Cut-Off Values for
Absolute Cardiac Perfusion With High Accuracy Using Quantitative [15O]H2O PET
Probability of hemodynamically signiﬁcant coronary artery disease (CAD) (y-axis) as deﬁned
by fractional ﬂow reserve (FFR) versus quantitative positron emission tomography (PET)
measurement of hyperemic myocardial blood ﬂow (MBF) (x-axis). All patients underwent
the shown [15O]H2O PET protocol and all patients were referred to the catheterization
laboratory for invasive coronary angiography (ICA) in conjunction with FFR measurements.
Optimal cutoff value for hyperemic MBF was 2.3 ml/min/g. Pa ¼ pressure proximal to the
lesion; Pd ¼ pressure distal to the lesion.
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Speciﬁcity, NPV, and diagnostic accuracy of quanti-
tative [15O]H2O PET were signiﬁcantly higher in
female patients both on a per-patient and a per-vessel
level. Age was categorized as #50 years, 51 to
60 years, 61 to 69 years, and $70 years. Although
there was no signiﬁcant difference in sensitivity
across the various age groups, age signiﬁcantly
inﬂuenced speciﬁcity and diagnostic accuracy on a
per-vessel level.
DISCUSSION
The main ﬁndings of this collaborative study are: 1)
the optimal cutoff value of quantitative [15O]H2O PET
MBF to detect hemodynamically signiﬁcant CAD is2.3 ml/min/g for hyperemic MBF and 2.5 for MFR;
2) MBF results indicate that diagnostic performance
of absolute hyperemic MBF surpasses that of ﬂow
reserve; 3) quantitative [15O]H2O PET-derived MBF
data provide an accuracy of 86% to detect ﬂow-
limiting CAD as deﬁned according to abnormal FFR;
and 4) age and sex are independent predictors of
hyperemic MBF and both affect diagnostic perfor-
mance of quantitative PET MBF.
One of the most fundamental issues when per-
forming quantitative MPI is to deﬁne optimal thresh-
olds of absolute perfusion. Previous studies reported
discriminatory values of hyperemic MBF and MFR
(10,12–15,17), but these trials were hampered by lim-
itations inherent in single-center studies. Indeed,
there is a lack of uniformity in reported cutoff
values, which may also be due to the use of different
PET radiotracers that likely provide different cutoff
values because their kinetic properties are vastly
different (3,4).
Hence, the increasing use of quantitative PET MPI
in clinical practice necessitates generalizable and
uniform cutoffs (2). The present study is, to the best
of our knowledge, the ﬁrst to determine cutoff values
for MBF as assessed with [15O]H2O PET by using ICA
together with FFR as the reference standard. In this
analysis, the ideal cutoff for absolute stress perfusion
was 2.3 ml/min/g and 2.5 for the perfusion reserve.
The stress perfusion threshold of 2.3 ml/min/g is in
line with the discriminatory value of <2.5 ml/min/g
observed by Kajander et al. (15) but higher than that
documented by Danad et al. (12) (1.86 ml/min/g),
which may be attributed to methodological differ-
ences between the studies. Interestingly, Kajander
et al. (12,15) incorporated, similar to the current study
design, the routine use of FFR measurements to
discern the functional relevance of CAD, which is
considered the reference standard.
We also found a signiﬁcantly higher area under
the curve for hyperemic MBF compared with MFR
to detect ﬂow-limiting stenoses, which is also in
line with previous studies (12,13,28). Dependency of
MFR on both baseline and hyperemic MBF likely
contributes to this ﬁnding because diminished stress
perfusion does not necessarily cause a reduction in
MFR. Although ﬂow reserve has been shown to be of
incremental value for prognosis (29), it seems that
hyperemic MBF outperforms MFR in the noninvasive
diagnosis of functionally relevant CAD. This ﬁnding
paves the way for stress-only protocols, obviating the
need of resting perfusion imaging with concomitant
reduction in radiation dose and scan acquisition time.
DIAGNOSTIC PERFORMANCE OF QUANTITATIVE
[15O]H2O PET MPI. Overall, the performance of [15O]
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FIGURE 5 Diagnostic Performance of Hyperemic MBF and MFR PET Imaging
Sensitivity, speciﬁcity, positive predictive value (PPV), negative predictive value (NPV), and
accuracy on a (A) per-patient and (B) per-vessel basis of quantitative PET MPI using
hyperemic MBF and MFR, respectively, as a perfusion parameter. Abbreviations as in
Figures 2 and 3.
TABLE 3 Results on a Per-Patient and Per-Vessel Level Using Hyperemic
MBF as a Perfusion Parameter to Assess Diagnostic Accuracy of [15O]H2O PET
Epicardial Stenosis
<30% or FFR >0.80
Epicardial Stenosis
>90% or FFR #0.80
At a per-patient level
Hyperemic MBF imaging No (obstructive) CAD Obstructive CAD
Positive (MBF #2.3 ml/min/g ) 27 101
Negative (MBF >2.3 ml/min/g ) 140 13
At a per-vessel level
Hyperemic MBF imaging No (obstructive) CAD Obstructive CAD
Positive (MBF #2.3 ml/min/g ) 106 151
Negative (MBF >2.3 ml/min/g) 583 23
FFR ¼ fractional ﬂow reserve; MBF ¼ myocardial blood ﬂow; PET ¼ positron emission
tomography; other abbreviations as in Table 1.
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1471H2O PET-derived quantitative perfusion parameters
shows promise for detecting obstructive CAD. Of all
patients with functionally relevant stenosis, as indi-
cated by FFR, only 13 (5%) were missed by quantita-
tive hyperemic MBF imaging, resulting in a
sensitivity of 89%; this ﬁnding mirrors previously
published (single-center) studies showing a weighted
sensitivity of 91% (4). However, most of these studies
were conducted with static uptake images of 82Rb
and 13NH3. More importantly, only 2 previous
investigations used FFR as a reference standard for
assessing hemodynamic relevance of intermediate
lesions (12,15), whereas most studies relied on ste-
nosis severity by ICA (4). The reliance on visual
grading of coronary stenosis severity is potentially
misleading and fails to accurately discern its physio-
logical signiﬁcance (30,31).
[15O]H2O PET rules out obstructive CAD with a high
NPV (92% per patient and 96% per vessel). Normal
perfusion (>2.3 ml/min/g) excludes the presence
of ﬂow-limiting CAD. However, diminished stress
perfusion does not necessarily imply presence of
hemodynamically compromised epicardial disease.
The observed PPV of 79% (59% on a per-vessel level)
reﬂects the discrepancy between MBF and FFR. The
proportion of discrepant ﬁndings between FFR and
hyperemic MBF in the present study wasw16%, which
is consistent with previous observations (32,33).
This mismatch between FFR and MBF does not
necessarily represent the failure of either technique
but likely indicates diffuse atherosclerotic or small
vessel disease, which may not cause localized pres-
sure gradients in FFR (33–36). The diagnosis of
obstructive CAD is often based on the ﬁnding of a
hemodynamically signiﬁcant focal epicardial stenosis
as indicated by FFR, reﬂecting hemodynamic rele-
vance of epicardial atherosclerosis (24). PET MBF
measures ﬂow across the entire coronary artery
network, consisting of both epicardial arteries and the
microvasculature (17). Abnormal perfusion in the
absence of signiﬁcant epicardial pressure gradients
is indicative of increased microvascular resistance
(10,37,38), which may result from remodeling and
vasoconstriction of arterioles due to endothelial
dysfunction (10,37). Therefore, FFR and perfusion
provide different information about the coronary ar-
tery tree and are not necessarily concordant (17,32,33).
Consequently, it is impossible to distinguish between
focal epicardial disease or small vessel or diffuse
nonobstructive CAD based on absolute MBF or MFR
alone. A hybrid imaging approach whereby PET is
combined with anatomical imaging enables differen-
tiation between microvascular and obstructive epi-
cardial disease.EFFECTS OF AGE AND SEX ON THE DIAGNOSTIC
ACCURACY OF QUANTITATIVE [15O]H2O MBF. Impaired
hyperemic MBF or MFR in the absence of obstructive
CAD indicates microvascular dysfunction, which can
be considered the functional counterpart of tradi-
tional CAD risk factors. These risk factors increase
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FIGURE 6 Diagnostic Performance of Quantitative PET
According to Different FFR Thresholds
ROC curve analysis showing the diagnostic performance of
hyperemic MBF on a per-vessel level using different FFR
thresholds to indicate hemodynamically signiﬁcant CAD.
Abbreviations as in Figures 1 to 4.
TABLE 5 Diagnostic Accuracy of Quantitative [15O]H2O PET MPI
for Detecting Angiographic Obstructive CAD
Patient-Based
Analysis
Vessel-Based
Analysis
$50% stenosis on ICA
Sensitivity 85 80
Speciﬁcity 84 82
PPV 82 60
NPV 87 92
Accuracy 85 81
$70% stenosis on ICA
Sensitivity 94 89
Speciﬁcity 77 76
PPV 67 40
NPV 96 98
Accuracy 83 78
Values are %.
ICA ¼ invasive coronary angiography; other abbreviations as in Tables 1, 3, and 4.
TABLE 4
Hyperemi
Per-patien
Sensitiv
Speciﬁc
NPV
PPV
Accurac
Per-vessel
Sensitiv
Speciﬁc
NPV
PPV
Accurac
Values are %
MPI ¼ m
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1472coronary microvascular resistance and hence limit
absolute myocardial perfusion (10,27,37), with sex
and age both demonstrating an effect on hyperemic
MBF (10,39,40); this may have important clinical
implications. The present study found that both
speciﬁcity and NPV are affected by age and sex but
with no signiﬁcant differences in accuracy across age.
The prevalence of diffuse nonobstructive disease in-
creases with age, which probably contributes to the
observed discrepancy between absolute perfusion
and FFR in elderly patients. Diffuse nonobstructive
disease is shown to negatively impact MBF (33–36),Diagnostic Accuracy of Quantitative [15O]H2O PET MPI Using
c MBF as a Perfusion Parameter
FFR Cutoff:
0.65
FFR Cutoff:
0.70
FFR Cutoff:
0.75
FFR Cutoff:
0.80 p Value
t analysis
ity 92 92 89 89 0.52
ity 78 80 81 84 0.62
95 95 93 92 0.26
67 71 74 79 0.22
y 83 84 84 86 0.66
analysis
ity 94 93 90 87 0.20
ity 81 82 83 85 0.28
99 98 98 96 0.02
44 49 54 59 <0.01
y 83 84 85 85 0.70
.
yocardial perfusion imaging; NPV ¼ negative predictive value; PPV ¼ positive pre-
e; other abbreviations as in Table 3.whereas intracoronary pressures as reﬂected by FFR
remain preserved.
With regard to sex, diagnostic accuracy is signiﬁ-
cantly higher in women. This ﬁnding could partially
be attributed to the lower prevalence of CAD in
female patients. Although sex differences in hyper-
emic MBF have been reported (10,39), no separate
quantitative MBF thresholds for men and women
have been used to identify myocardial ischemia.
Therefore, recognition of sex-related differences in
quantitative PET will permit deﬁnition of optimal
gender-speciﬁc thresholds when interpreting quanti-
tative MBF results. It remains elusive whether the
present ﬁndings are applicable only to quantitative
MBF. Clearly, large prospective studies are warranted
to determine whether age- and sex-corrected MBF
reference values should be incorporated in diagnostic
cardiac PET protocols.
STUDY LIMITATIONS. There are a number of limita-
tions to our study. Although FFR was measured in
numerous intermediate stenoses, some assumptions
pertaining to missing values were made based on
the ﬁndings of Tonino et al. (30), who reported
that subtotal stenoses are virtually always (96%)
hemodynamically signiﬁcant. Also, only quantitative
grading of PET images was performed and no
comparison with visual MPI was provided, although
previous studies have demonstrated that quantitative
PET MPI outperforms visual PET diagnostically (8,9).
Both intracoronary and intravenous administration of
adenosine was used to achieve vasodilation during
FFR measurements, although intravenous adminis-
tration is generally the reference standard (31).
However, there was no difference in diagnostic
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FIGURE 7 Quantitative Relationship Between
Absolute Myocardial Perfusion and FFR
Scatterplots demonstrating the quantitative relationship between
fractional ﬂow reserve and (A) hyperemic MBF, (B) myocardial
ﬂow reserve, and (C)MFRcorr. Abbreviations as in Figures 1 and 3.
TABLE 6 Univariate and Multivariable Regression Analysis
Describing the Relationship Between Hyperemic MBF,
CAD Risk Factors, and Functional CAD Severity
Univariate
Analysis
Multivariable
Analysis
b p Value b p Value
Age, yrs –0.02 <0.01 –0.02 0.02
(Female) sex 1.07 <0.001 0.89 <0.001
BMI, kg/m2 –0.02 0.11 0.001 0.96
Diabetes mellitus type 2 –0.42 0.01 –0.27 0.13
Hypertension –0.29 0.02 –0.24 0.04
Hypercholesterolemia –0.007 0.95 0.10 0.35
Smoking history –0.23 0.10 –0.21 0.08
Family history –0.09 0.49 –0.24 0.04
FFR #0.80 –1.48 <0.001 –0.79 <0.001
Abbreviations as in Tables 1 and 3.
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1473performance of quantitative PET to detect signiﬁcant
CAD as indicated by FFR achieved by either intra-
coronary or intravenous administration of adenosine.
Although care was taken to match coronary anat-
omy (obtained by using ICA) with PET perfusion
territories, some misclassiﬁcation between coronary
arteries and their corresponding vascular regions in
the PET scans may have occurred. In addition,
vasoactive medication was not discontinued beforeTABLE 7 The Inﬂuence of Sex and Age on the Diagnostic Performance of
[15O]H2O Hyperemic MBF Imaging
Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%) Accuracy (%)
Patient-based analysis
Sex
Male (n ¼ 164) 90 70 80 85 82
Female (n ¼ 117) 82 94 75 96 92
p value 0.27 <0.001 0.60 0.02 0.02
Age, yrs
#50 (n ¼ 40) 92 79 65 96 83
51–60 (n ¼ 96) 88 92 86 93 91
61–69 (n ¼ 105) 87 85 81 89 86
$70 (n ¼ 40) 91 59 75 83 78
p value 0.93 <0.01 0.33 0.55 0.22
Vessel-based analysis
Sex
Male (n ¼ 491) 84 75 59 92 78
Female (n ¼ 372) 74 96 57 98 94
p value 0.19 <0.001 0.86 <0.001 <0.001
Age
#50 (n ¼ 123) 78 87 50 96 85
51–60 (n ¼ 297) 80 90 65 95 88
61–69 (n ¼ 320) 82 84 58 95 83
$70 (n ¼ 123) 92 74 57 96 79
p value 0.54 <0.001 0.57 0.96 <0.001
Abbreviations as in Tables 3 and 4.
PERSPECTIVES
COMPETENCY IN PATIENT CARE: Quantitative
MPI may be used to help select patients for coronary
angiography and reduce the need for invasive
measurement of fractional ﬂow reserve.
TRANSLATIONAL OUTLOOK: Comparative studies
of contemporary single-photon emission computed
tomography/CT and cardiac PET/computed tomo-
graphy perfusion imaging technologies should be
undertaken to determine their relative diagnostic
utility.
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1474PET imaging, which may have negatively affected
the sensitivity of quantitative PET. Furthermore,
although the underlying modeling procedures were
similar for all institutions, differences in deﬁning
arterial input function, spillover corrections, and
automatic deﬁnition of myocardial segments between
institutions may have inﬂuenced the generated
perfusion values. Finally, obtained cutoff values may
not be applicable to other PET ﬂow tracers, such as
13NH3 and 82Rb, although several studies have shown
that 13NH3 provides comparable estimates of MBF
over a wide range of ﬂow values (41,42).
CONCLUSIONS
This is the ﬁrst collaborative study to deﬁne cutoff
values for absolute hyperemic MBF and MFR using
ICA in conjunction with FFR as the reference stan-
dard. The optimal cutoff values for detecting ﬂow-
limiting stenosis were 2.3 ml/min/g for hyperemic
MBF and 2.5 for MFR. Absolute hyperemic MBF
measurements were superior to MFR for diagnosing
hemodynamically signiﬁcant CAD, implying that
stress-only protocols would sufﬁce in diagnosticPET protocols. [15O]H2O PET provides high diag-
nostic accuracy, but both sex and age affect its
accuracy.
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